Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Pilic Johannes |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Bordag, N; Pilic, J; Bourgeois, BMR; Madl, T; Wolf, P; Golob-Schwarzl, N
eIF1A and eIF3B as new treatment options in psoriasis: a metabolic perspective
ÖGDV Science Days 2022; SEP 15-17, 2022; Bad Gastein, Austria. 2022.
[Oral Communication]
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
Eukaryotic translation initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment
J INVEST DERMATOL. 2022; 142(12): S244-S244.
[Poster]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
ESDR374 - Eukaryotic translation initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment
E-Poster European Society for Dermatological Research. 2022; -51st Annual ESDR Meeting; Sep 28-Oct 2, 2022; Amsterdam, Netherlands.
[Poster]
FullText
Kaufmann, L; Blatterer, J; Mayer, AL; Auinger, L; Pilic, J; Schaflinger, E; Khan, AS; Tatrai, B; Abbasi, SW; Zeeshan Ali, M; Abbasi, AA; Graier, W; Al Kaissi, A; Wagner, K; Malli, R; Ahmad Khan, M; Windpassinger, C
Functional analysis of a biallelic N-terminal frameshift mutation in ZMPSTE24 escaping the predicted lethal phenotype
Med Uni Graz: DOCTORAL DAY 2022; FEB 10, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Kaufmann, L; Pilic, J; Mayer, AL; Auinger, L; Blatterer, J; Graier, W; Al Kaissi, A; Petek, E; Wagner, K; Malli, R; Ahmad Khan, M; Windpassinger, C
Functional analysis of a biallelic N-terminal frameshift mutation in ZMPSTE24 escaping the predicted lethal phenotype
21. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 29-30, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
FullText
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis
4th Inflammatory Skin Disease Summit 2021. 2021; -4th Inflammatory Skin Disease Summit 2021; Nov 3 - 6, 2021; New York, USA.
[Poster]
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis
J INVEST DERMATOL. 2021; 141(10): S177-S177.
[Poster]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential therapeutic targets in psoriasis
EXP DERMATOL. 2021; 30: 5-6.
[Oral Communication]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf,P
Eukaryotic Translation Initiation Factors (eIFs) as Potential Targets in Psoriasis
Science Days 2021. 2021; -Science Days ; Jun 25-26, 2021; Mondsee, Austria.
[Poster]
Pilic, J; Gottschalk, B; Graier, W; Malli, R
Hexokinase 1 prevents mitochondrial division during energy stress
EUR BIOPHYS J BIOPHY. 2021; 50(SUPPL 1):200-200.
[Poster]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf,P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis.
ÖGDV Jahrestagung. 2020; -ÖGDV; DEC 4-5, 2020; Vienna, AUSTRIA.
[Onlinepräsentation]